1 / 23

Safety of irreversible electroporation treatment for metastatic disease in humans

Safety of irreversible electroporation treatment for metastatic disease in humans. Silk Mikhail ; Wimmer, Thomas; Getrajdman, George; Durack, Jeremy; Sofocleous, Constantinos T.; Solomon, Stephen B. Interventional Radiology & Image Guided Therapies

chaz
Télécharger la présentation

Safety of irreversible electroporation treatment for metastatic disease in humans

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Safety of irreversible electroporation treatment for metastatic disease in humans Silk Mikhail; Wimmer, Thomas; Getrajdman, George; Durack, Jeremy; Sofocleous, Constantinos T.; Solomon, Stephen B. Interventional Radiology & Image Guided Therapies Memorial Sloan Kettering Cancer Center. New York, NY Email:sofoclec@mskcc.org

  2. Agenda • Background on Ablation Devices • Physics (RFA, MWA, IRE) • Pre-Clinical Data • Clinical Applications

  3. Thermal ablation uses Electromagnetic Spectrum MWA 300GHZ 300 MHz R F A 3HZ Thermal ablation uses the EM frequencies of 3 Hz and 300 GHz.

  4. Irreversible Electroporation • Electroporation • Electric pulses create tiny holes in the cell • Temporary as long as the energy is low • 360 V/cm • Chemotherapy and Genetic therapy delivery • “Irreversible” • Higher energy • 680 V/cm1 • Create permanent holes in the cell • Cell loses essential molecules and internal signals tell the cell to die

  5. Electroporation • Reversible electroporation is used to allow genes and drugs to enter cells (300-600 V/cm) • Direct current pulse leads to elevation of transmembrane potentials creating permanent cell membrane pores: ~1,500 V/cm • Strong electric fields applied across a cell can cause: • Irreversible permeabilization • of the cell membrane: “IRE”

  6. How IRE kills cells

  7. Advantages of IRE • IRE is non-thermal • Little to no scar tissue formation • Structural Protein Sparing • Nerves and bile ducts in the area of ablation have the potential to heal after treatment • No heat sink effect • Compared to thermal techniques where blood flow dissipates heat. Electric pulses are not effected by blow flow.

  8. Patient Demographics

  9. Multiple IRE electrodes to treat larger lesions minimum: 2 parallel electrodes spaced 1.5-2 cm

  10. NO Heat Sink Effect

  11. Case close to bile duct and major vein • Post-Tx • 3 mo. f/u MRI Pre-Tx Tx

  12. No tumor for +778 days

  13. Perivascular/periductal Liver Metastases28 patients/ 65 tumors: 1 arrhythmia; 1 PV thrombosis (3%) 6 months: 92% Complete Ablation Kingham P et al: IRE for Perivascular Hepatic Malignant Tumors. J Am Coll Surg 2012; 215(3): 379-87

  14. Animal Lung IRE LUNG close to bronchus Post IRE: GGO Applicators 1 week 3 weeks

  15. Tumor near airway • Post-Tx • 3 mo. PET scan • Pre-Tx • Tx

  16. IRE as an Ablation Tool: Potential Advantages • Non-Thermal: -Application in Locations non eligible for Thermal Ablation -Limit recurrences near vessels by avoiding the “heat sink” effect • Cellular Kill Mechanism Avoids Damage to: - Extracellular Matrix. This may result in fewer complications: Near Bile Ducts, Intestines, Ureters, Bronchi, Vital structures.

  17. 51 year old with rectal cancer recurrence near rectum

  18. NO tumor for +565 days

  19. IRE Rectal Wall Transmural Necrosis; No Perforation at 14 days

  20. Applications: IRE Where Thermal ablation is NOT feasible • Pancreas: Locally advanced adenocarcinoma 100% success at 90 days.Martin RC e al J Am Coll Surg 2012; 215(3): 361-9 • Perivascular Liver Tumors. Kingham P et al: IRE for Perivascular Hepatic Malignant Tumors. J Am Coll Surg 2012; 215(3): 379-87 • Prostate: A potential Therapeutic Paradigm Shift. Ward JF Curr Opin Urol 2012; (2): 104-108 • Intracranial: Canine brain Surgery. Garcia PA Conf Proc IEEE Eng Med Biol Soc 2009: 6513-6. and Technol Cancer Res Treat 2011; 10(1): 73-83 • Blood Brain barrier Disruption: Rat Hjoui M et al. MRI study on reversible and irreversible electroporation induced blood brain barrier disruption. Plos One. 2012;7(8) • Small Intenstine: Rat: Complete ablation but recovery of Epithelium in 3 weeks. Phillips MA. Br J Cancer 2012; 31; 106(3): 490-5

  21. Enhancing Irreversible Electroporation A zone of Reversible electroporation Surrounds the Area of IRE A lethal agent can be targeted to the reversible zone: Electrochemotherapy Gene Electrotransfer Electrochemotherapy : A new technological approach in treatment of Liver Metastases. Edhemovic et al Technol Cancer Res Treat 2011 Oct; 10(5):475-85 Treatment Planning of Electroporation-Based medical Interventions: electrochemotherapy, gene electrotransfer and IRE Phys Med Biol 2012; 7;57(17)5425-40 Reversible Irreversible Model assumes 360 V/cm threshold for reversible and 680 V/cm threshold for irreversible

  22. Conclusion • Unlike Thermal Ablation, IRE, can be performed in close proximity to bile ducts, major vessels, bladder, rectum, and nerves, with an acceptable safety profile. • Longer term follow up is performed to determine efficacy. • Further research will determine the potential of this new ablation technology

  23. sofoclec@mskcc.org

More Related